{ "schema_version": 1, "metadata": { "title": "A股未来一年周期展望与五种AI方法论会商", "as_of": "2026-08-23", "market_data_cutoff": "2026-08-20", "forecast_start": "2026-08-23", "forecast_end": "2027-08-23", "expert_snapshot_version": "2026.08.23-v3", "expert_runtime": "dsh 0.1.1-rc.2 / headless；具体模型与reasoning配置未冻结", "expert_method": "五个隔离 DSH 工作区分别安装一个专家 Skill；首轮做提示与上下文隔离，第二轮用统一事实底稿交叉质询。Round 3产物未冻结具体模型与reasoning配置，只能证明五次Skill调用，不能视为认知或统计独立样本。", "expert_disclosure": "五个姓名均指基于系统 Skill 的 AI 方法论角色；相关真人未参与、未审核、未背书。", "committee_vote_snapshot": "Round 1/2使用旧事实快照；Round 3用修正后的2026最新财报重新执行五个Skill并留存完整提示词与原始输出。最终动作采用Round 3与严格门禁，旧票中的CORE/SATELLITE只作历史分歧记录。", "expert_run_artifact": "docs/research-data/a-share-cycle-expert-runs-2026-08-23.json", "expert_run_input_sha256": "a7f9052ca5014a89e12a3af7ec41363af7b9dad0aa186a1cbf691342ab8bf1dd", "probability_semantics": "本期不提供未经历史校准的情景概率、胜率或收益承诺；主/备选/压力只表示研究排序。", "investment_boundary": "所有股票均为研究观察对象，不是保本推荐、买入指令或目标价。任一门禁未完成都不触发买入结论。", "artifact_provenance": "人工策展的结构化研究JSON + scripts/research/render-a-share-cycle-outlook.ts；JSON不是模型输出的无损逐字转录" }, "verdict": { "headline": "截至2026年7月，事实与“供给较强、商品和住房需求偏弱、利润改善集中”一致；未来一年是否延续仍待信用、财政执行和盈利广度验证。", "summary": "研究主情景排序为结构分化延续，但它只是待证假设。最终采用“现金流资产 + 有订单与利润验证的新动能”的观察框架；实时估值、自由现金流和最新财报未全部过门，因此没有任何可执行 CORE 或 SATELLITE。", "primary_watch": "600900 长江电力", "research_watch": [ "600900 长江电力", "000333 美的集团", "300750 宁德时代", "600941 中国移动", "600519 贵州茅台", "600276 恒瑞医药" ], "rejected": [] }, "latest_council": { "round": "Round 3 · 最新财报事实门复核", "executed_at": "2026-08-23T16:33:49.865Z", "artifact": "./research-data/a-share-cycle-expert-runs-2026-08-23.json", "execution": "5/5 exit 0，5/5 JSON解析成功；并发2；DSH 0.1.1-rc.2 headless；具体模型与reasoning配置未冻结", "scenario_consensus": "5/5把结构市/数据待确认列第一；4/5把二次探底列第二，1/5把盈利扩散列第二；不提供概率。", "theme_results": [ { "name": "电网", "watch": 5, "reject": 0 }, { "name": "半导体", "watch": 5, "reject": 0 }, { "name": "创新药", "watch": 5, "reject": 0 }, { "name": "家电/自动化", "watch": 5, "reject": 0 }, { "name": "高股息", "watch": 5, "reject": 0 }, { "name": "机器人", "watch": 4, "reject": 1 } ], "stock_results": [ { "name": "长江电力", "watch": 5, "reject": 0, "action": "WATCH；补自由现金流与实时利差" }, { "name": "美的集团", "watch": 5, "reject": 0, "action": "WATCH；扣非与现金转化待核" }, { "name": "宁德时代", "watch": 5, "reject": 0, "action": "WATCH；产能回报与估值未过" }, { "name": "恒瑞医药", "watch": 5, "reject": 0, "action": "WATCH；单期现金失守，等待第二期证伪" }, { "name": "中国移动", "watch": 5, "reject": 0, "action": "WATCH；补分红覆盖、资本回报与实时估值" }, { "name": "贵州茅台", "watch": 5, "reject": 0, "action": "WATCH；重新评审但不升级" } ], "disagreements": [ "情景第一顺位一致，但第二顺位分歧：4/5更担心二次探底，段永平式角色把盈利扩散列第二。", "修正恒瑞扣非净利并明确连续期FAIL后，六股全部为5/5 WATCH；WATCH只表示证据未闭环，不证明安全。", "机器人仍有1/5 REJECT；其他主题均为5/5 WATCH，没有任何主题达到可执行PASS。" ] }, "scenarios": [ { "id": "base", "name": "基准：结构市延续", "priority": "主情景", "description": "现有报告只够把状态暂定为结构市 / 数据不足；六项开关尚未形成可确认的广泛上行或压力共振。", "confirm": [ "不满足备选情景或压力情景的完整规则", "或可评估指标少于5项，自动标记数据不足", "当前单期证据不当作连续期确认" ], "falsify": "达到备选情景或压力情景的互斥规则。" }, { "id": "upside", "name": "乐观：盈利扩散", "priority": "备选情景", "description": "财政资金与信用传导改善，盈利从电子、有色等少数行业扩散至中游设备、可选消费和金融，市场宽度恢复。", "confirm": [ "六项中至少5项可评估", "至少4项满足上行阈值，合计得分≥+3", "每项均达到表中规定的连续发布期" ], "falsify": "上行项降至3项及以下、合计得分低于+3，或可评估项少于5。" }, { "id": "downside", "name": "悲观：二次探底", "priority": "压力情景", "description": "地产和内需继续收缩，叠加出口、能源或外部利率冲击；高估值成长与强周期率先压缩估值。", "confirm": [ "六项中至少5项可评估", "至少4项满足压力阈值，合计得分≤-3", "外部事件本身不触发切换，必须反映在六项国内指标" ], "falsify": "压力项降至3项及以下、合计得分高于-3，或可评估项少于5。" } ], "scenario_state_rule": "每项按本报告冻结阈值记+1/0/-1。可评估≥5且上行≥4、总分≥+3时为盈利扩散；否则，可评估≥5且压力≥4、总分≤-3时为二次探底；其余为结构市/数据待确认。未知或断档记0并标pending，不可跨期拼接。当前覆盖不足，状态为base_pending。阈值是本报告研究门槛，不是官方标准或历史校准模型。", "scenario_scorecard": [ { "name": "规模以上工业增加值", "current": "+5.3%（2026年1—7月）", "upside": "累计同比≥6%，连续3次发布", "downside": "累计同比≤4%，连续3次发布", "source_ids": ["nbs-july"] }, { "name": "社会消费品零售", "current": "+1.2%（2026年1—7月）", "upside": "累计同比≥3%，连续3次发布", "downside": "累计同比≤0%，连续3次发布", "source_ids": ["nbs-retail"] }, { "name": "商品房销售额", "current": "-13.1%（2026年1—7月）", "upside": "累计同比≥-5%，连续3次发布", "downside": "累计同比≤-15%，连续3次发布", "source_ids": ["nbs-july"] }, { "name": "PPI环比", "current": "-0.7%（2026-07；单期）", "upside": ">0%，连续3月", "downside": "<0%，连续3月", "source_ids": ["nbs-prices"] }, { "name": "工业利润与广度", "current": "总额+18.7%，电子贡献约45%（2026H1）", "upside": "利润≥10%且电子增量贡献≤30%，连续2次", "downside": "利润<5%，连续2次", "source_ids": ["nbs-profits"] }, { "name": "政府性基金收入", "current": "-21.6%（2026H1；单期）", "upside": "累计同比≥-5%，连续2次发布", "downside": "累计同比≤-15%，连续2次发布", "source_ids": ["mof-h1"] } ], "cycle_phases": [ { "period": "2026.08—10", "name": "初始基线与财报复核", "state": "预定复核，不是必然阶段", "focus": "建立六项开关与公司最新财报基线；成交和市场宽度在冻结数据接入前只记为证据缺口。", "signals": ["六项情景开关", "工业利润广度", "公司自由现金流"] }, { "period": "2026.11—2027.02", "name": "财政与信用复核", "state": "预定复核，不是传导承诺", "focus": "观察电网、设备更新和AI资本开支的招标、合同负债与回款，区分真实需求和政策叙事。", "signals": ["财政执行", "M1-M2剪刀差", "居民贷款", "订单与合同负债"] }, { "period": "2027.03—05", "name": "年报与一季报裁决", "state": "年报与一季报复核", "focus": "只有收入、毛利、现金流和订单同时改善的主题才能从WATCH升级。", "signals": ["盈利上修比例", "应收/存货相对营收", "板块广度"] }, { "period": "2027.06—08", "name": "拥挤度再定价", "state": "估值与产能复核", "focus": "检查资本开支是否把短缺变成过剩；高股息检查现金收益率是否已被拥挤交易买没。", "signals": ["产能利用率", "产品价格/毛利", "股息与无风险利率利差", "估值分位"] } ], "macro_evidence": [ { "label": "2026H1 GDP", "value": "+4.7%", "detail": "Q1 +5.0%，Q2 +4.3%，增长动能放缓。", "tone": "watch", "source_ids": ["nbs-gdp"] }, { "label": "1—7月工业", "value": "+5.3%", "detail": "装备制造 +9.7%，高技术制造 +13.8%；供给侧明显强于需求侧。", "tone": "positive", "source_ids": ["nbs-july"] }, { "label": "1—7月社零", "value": "+1.2%", "detail": "服务零售 +5.0%，消费是结构修复而非总量繁荣。", "tone": "watch", "source_ids": ["nbs-retail", "nbs-services"] }, { "label": "地产开发投资", "value": "-19.2%", "detail": "销售面积 -11.8%、销售额 -13.1%、新开工 -24.0%，尚无基本面反转。", "tone": "negative", "source_ids": ["nbs-july"] }, { "label": "7月CPI / PPI", "value": "+0.5% / +3.5%", "detail": "核心CPI +0.9%；PPI环比 -0.7%，再通胀动能并不稳。", "tone": "watch", "source_ids": ["nbs-prices"] }, { "label": "H1工业利润", "value": "+18.7%", "detail": "电子制造贡献约45%的增速；盈利改善真实但集中。", "tone": "positive", "source_ids": ["nbs-profits"] }, { "label": "8月LPR", "value": "3.0% / 3.5%", "detail": "总量利率偏低，但信用向居民和私人部门传导仍是核心变量。", "tone": "neutral", "source_ids": ["lpr"] }, { "label": "H1政府性基金收入", "value": "-21.6%", "detail": "地方土地出让收入 -31.5%，中央财政托底与地方财力约束同时存在。", "tone": "negative", "source_ids": ["mof-h1"] }, { "label": "7月PMI / 新订单", "value": "49.2 / 48.5", "detail": "两者均低于50；高技术制造PMI 53.3，结构分化明显。", "tone": "watch", "source_ids": ["nbs-pmi"] } ], "themes": [ { "id": "grid", "name": "电网、特高压与电力数字化", "grade": "B-", "committee": { "pass": 1, "watch": 4, "reject": 0 }, "latest_committee": { "pass": 0, "watch": 5, "reject": 0 }, "committee_basis": "Round 3最新事实逐主题复核；旧轮次来自grid_ai合并桶", "thesis": "国家电网五年投资计划规模大、周期长，招标和回款可跟踪；但总盘子不能替代公司份额、毛利与现金回款验证。", "evidence": ["国家电网“十五五”固定资产投资计划4万亿元、较“十四五”增长40%", "跨区输电、配网与数智化提供需求方向，但尚未证明单家公司增量"], "candidate": "600406 国电南瑞（行业观察，未纳入六股委员会评级）", "hard_fail": "连续两个季度订单增速低于10%，合同负债下降且经营现金流显著落后净利润。", "source_ids": ["nea-grid", "nari-annual"] }, { "id": "semiconductor", "name": "AI算力与国产集成电路制造", "grade": "B-", "committee": { "pass": 1, "watch": 4, "reject": 0 }, "latest_committee": { "pass": 0, "watch": 5, "reject": 0 }, "committee_basis": "Round 3最新事实逐主题复核；旧轮次来自grid_ai合并桶", "thesis": "电子制造利润高增与晶圆厂利用率改善提供基本面证据，但科创板整体估值很高，只能选盈利兑现环节。", "evidence": ["电子制造H1利润 +96.9%", "中芯国际2026Q2收入同比 +36.1%、毛利率25.3%、利用率93.7%"], "candidate": "688981 中芯国际（高波动行业观察）", "hard_fail": "利用率低于85%、毛利率低于22%，或存货连续两个季度快于收入。", "source_ids": ["nbs-profits", "smic-q2"] }, { "id": "pharma", "name": "创新药出海与授权交易", "grade": "B-", "committee": { "pass": 2, "watch": 3, "reject": 0 }, "latest_committee": { "pass": 0, "watch": 5, "reject": 0 }, "committee_basis": "Round 3最新事实逐主题复核", "thesis": "研发与产品销售可形成长期IP周期，但一次性授权首付款不能线性外推。", "evidence": ["恒瑞2025创新药销售 +26.09%、经营现金流 +51.36%", "2026H1创新药销售 +16.38%，但营收 -1.94%、扣非净利 -12.71%、经营现金流 -53.80%"], "candidate": "600276 恒瑞医药", "hard_fail": "剔除许可收入后核心产品增速降至个位数，或关键三期临床失败。", "source_ids": ["hengrui-annual", "hengrui-h1"] }, { "id": "appliance", "name": "家电更新、节能设备与工业自动化", "grade": "C+", "committee": { "pass": 0, "watch": 4, "reject": 1 }, "latest_committee": { "pass": 0, "watch": 5, "reject": 0 }, "committee_basis": "Round 3最新事实逐主题复核；旧轮次制造/消费桶仅作历史参考", "thesis": "补贴、海外渠道与ToB自动化提供多条需求线，但补贴前置、关税与现金流背离限制确定性。", "evidence": ["以旧换新销售额超过1万亿元", "美的2026Q1收入 +2.55%、经营现金流 +1.45%，但扣非净利 -14.02%"], "candidate": "000333 美的集团", "hard_fail": "经营现金流连续下降、海外毛利率明显恶化，或补贴后家电零售仍低于2%。", "source_ids": ["ndrc-tradein", "midea-q1", "midea-annual"] }, { "id": "dividend", "name": "高股息与可解释现金流", "grade": "C+", "committee": { "pass": 0, "watch": 5, "reject": 0 }, "latest_committee": { "pass": 0, "watch": 5, "reject": 0 }, "committee_basis": "Round 3最新事实逐主题复核", "thesis": "只保留经营现金流覆盖派息、资产寿命与资本开支可解释的公司；“红利”不是统一因子。", "evidence": ["长江电力2026Q1现金转化1.73×，但维护性资本开支与实时利差待核", "中国移动2026H1经营现金流 +37.0%、自由现金流539亿元（+111.6%），但通信服务收入 -5.7%"], "candidate": "600900 长江电力；600941 中国移动仅条件观察", "hard_fail": "派息靠负债、处置资产或削减必要资本开支维持。", "source_ids": ["cypc-q1", "cypc-annual", "cmcc-h1", "cmcc-annual"] }, { "id": "robotics", "name": "具身智能与机器人", "grade": "C / 影子验证", "committee": { "pass": 0, "watch": 4, "reject": 1 }, "latest_committee": { "pass": 0, "watch": 4, "reject": 1 }, "committee_basis": "Round 3最新事实逐主题复核；旧轮次来自manufacturing合并桶", "thesis": "政策支持与装备制造增长成立，但多数标的仍缺稳定订单、单位经济和自由现金流。", "evidence": ["政府工作报告明确支持具身智能", "装备制造1—7月 +9.7%，不能等同于机器人企业盈利"], "candidate": "不列稳健核心股，仅维护订单与交付影子清单", "hard_fail": "交付时点持续后延、只见概念成交而无真实终端订单，或扩产导致毛利连续下滑。", "source_ids": ["gov-work-report", "nbs-july"] } ], "stocks": [ { "symbol": "600900", "name": "长江电力", "decision": "watch", "layer": "WATCH-1 / 五视角一致但质量与估值待补", "financial_cutoff": "2026Q1 / 披露2026-04-30", "committee": { "core": 5, "satellite": 0, "watch": 0, "reject": 0 }, "latest_committee": { "watch": 5, "reject": 0 }, "metrics": [ { "label": "2026Q1营收", "value": "181.12亿元", "change": "+6.44%" }, { "label": "归母净利", "value": "67.61亿元", "change": "+30.50%" }, { "label": "经营现金流", "value": "117.11亿元", "change": "-1.15%" }, { "label": "现金转化 / 扣非", "value": "1.73× / +19.20%", "change": "非经常项影响归母增速" } ], "reason": "六座梯级水电站构成稀缺、长寿命资产；2026Q1盈利改善、现金转化仍强，但经营现金流略降且维护性资本开支尚未拆出，故只能列优先WATCH。", "catalysts": ["来水与发电量改善", "利率下行提高现金流资产相对价值", "电力市场化机制优化"], "valuation_gate": "只有当股息率相对长期无风险利率仍留有足够利差、且来水正常化后的自由现金流能覆盖分红时，才从研究CORE转为可执行候选。", "gate_bands": { "pass": "维护性资本开支后自由现金流/现金分红≥1.2，股息率较10年国债收益率利差≥2pct，且来水正常化后仍满足。", "watch": "自由现金流口径、净债务或实时利差任一未知；或覆盖倍数1.0—1.2、利差1—2pct。", "fail": "自由现金流不能覆盖分红、派现率低于承诺，或发电量与结算电价任一连续两期显著下降。" }, "hard_fails": ["年度派现率低于70%", "经营现金流/现金分红低于1.5", "发电量与平均结算电价同时同比下降超过5%"], "source_ids": ["cypc-q1", "cypc-annual"] }, { "symbol": "000333", "name": "美的集团", "decision": "watch", "layer": "WATCH-2 / 现金转化待核", "financial_cutoff": "2026Q1 / 披露2026-04-30", "committee": { "core": 0, "satellite": 3, "watch": 2, "reject": 0 }, "latest_committee": { "watch": 5, "reject": 0 }, "metrics": [ { "label": "2026Q1营收", "value": "1,310.99亿元", "change": "+2.55%" }, { "label": "归母净利", "value": "126.75亿元", "change": "+2.03%" }, { "label": "经营现金流", "value": "145.29亿元", "change": "+1.45%" }, { "label": "现金转化 / 扣非", "value": "1.15× / -14.02%", "change": "底层盈利承压" } ], "reason": "多品类家电、全球渠道和ToB自动化分散单一业务风险；2026Q1现金转化尚可，但收入利润低个位数、扣非利润转弱，不具备升级条件。", "catalysts": ["海外本地化收入继续增长", "ToB业务兑现", "补贴后仍保持自然需求"], "valuation_gate": "先解释现金流下降来自营运资本、并购还是结构性回款恶化；经营现金流/归母净利保持≥1.0、ROE≥18%，再按保守所有者收益估值。", "gate_bands": { "pass": "现金转化率≥1.0、ROE≥18%，海外毛利稳定，且营运资本与资本开支变动已解释。", "watch": "现金转化率0.8—1.0，或现金流下降、并购与营运资本影响尚未拆清。", "fail": "现金转化率<0.8，或收入/利润转负，或海外毛利连续两期明显恶化。" }, "hard_fails": ["现金转化率低于0.8", "收入或利润转负", "海外毛利率显著下滑"], "source_ids": ["midea-q1", "midea-annual"] }, { "symbol": "300750", "name": "宁德时代", "decision": "watch", "layer": "WATCH-2 / 周期成长与产能待核", "financial_cutoff": "2026H1 / 披露2026-07-26", "committee": { "core": 2, "satellite": 3, "watch": 0, "reject": 0 }, "latest_committee": { "watch": 5, "reject": 0 }, "metrics": [ { "label": "2026H1营收", "value": "2,769.17亿元", "change": "+54.80%" }, { "label": "归母净利", "value": "432.84亿元", "change": "+41.98%" }, { "label": "经营现金流", "value": "602.17亿元", "change": "+2.61%" }, { "label": "现金转化", "value": "1.39×", "change": "营收/利润快于现金流" } ], "reason": "2026H1收入、利润和现金转化跨过数量门，基本面明显强化；但现金流增速远低于利润，且产能、ASP、海外项目回报和实时估值未过门。", "catalysts": ["储能需求和海外基地放量", "产品结构提升", "资本回报与分红兑现"], "valuation_gate": "营收增速≥10%、销量增速≥15%、经营现金流/归母净利≥1.2、ROE≥20%，并要求估值没有把未来两年增长一次性贴现。", "gate_bands": { "pass": "营收≥10%、销量≥15%、现金转化率≥1.2、ROE≥20%，且利用率、ASP、资本开支回报和实时估值全部通过。", "watch": "一项质量门未过，或预收/应付对现金流影响、海外项目回报、实时估值任一未知。", "fail": "两项质量门连续两期未过，或利用率与ASP同时下行而资本开支继续扩张。" }, "hard_fails": ["利用率和产品价格连续两季下行但资本开支仍扩", "两项质量门槛连续失守", "海外项目重大减值"], "source_ids": ["catl-h1", "catl-annual"] }, { "symbol": "600276", "name": "恒瑞医药", "decision": "watch", "layer": "WATCH-2 / 单期现金失守待二期证伪", "financial_cutoff": "2026H1 / 披露2026-08-19", "committee": { "core": 1, "satellite": 3, "watch": 1, "reject": 0 }, "latest_committee": { "watch": 5, "reject": 0 }, "metrics": [ { "label": "2026H1营收", "value": "154.56亿元", "change": "-1.94%" }, { "label": "归母 / 扣非", "value": "44.65 / 37.30亿元", "change": "+0.34% / -12.71%" }, { "label": "经营现金流", "value": "19.87亿元", "change": "-53.80%" }, { "label": "现金转化 / 创新药", "value": "0.45× / +16.38%", "change": "触发复核，尚非持续期FAIL" } ], "reason": "创新药销售仍增长，但2026H1收入、扣非与现金流明显转弱，现金转化跌至0.45；海外授权高基数能解释部分变化。单期失守先列WATCH，只有第二个报告期继续恶化或其他硬失效发生才转REJECT。", "catalysts": ["核心产品放量", "国际授权里程碑实际到账", "关键临床与审批成功"], "valuation_gate": "分拆产品销售与许可收入；剔除一次性授权后核心销售仍保持两位数增长，经营现金流/归母净利≥1.0。", "gate_bands": { "pass": "剔除许可首付款后核心产品销售≥10%、现金转化率≥1.0，关键临床与实时估值均通过。", "watch": "剔除许可后核心销售0—10%，现金转化率单期<1.0，或现金流中一次性授权影响未拆清。", "fail": "剔除许可后核心销售转负、关键三期失败/延期，或现金转化率<1.0且现金回报连续两个报告期恶化。" }, "hard_fails": ["剔除许可收入后主业增速转负", "关键三期临床失败或审批延期", "研发资本化持续上升但现金回报未改善"], "source_ids": ["hengrui-h1", "hengrui-annual"] }, { "symbol": "600941", "name": "中国移动", "decision": "watch", "layer": "WATCH-2 / 分红覆盖、资本回报与估值待核", "financial_cutoff": "2026H1 / 披露2026-08-13", "committee": { "core": 0, "satellite": 0, "watch": 3, "reject": 2 }, "latest_committee": { "watch": 5, "reject": 0 }, "metrics": [ { "label": "2026H1营收", "value": "5,380.35亿元", "change": "-1.1%" }, { "label": "归母净利", "value": "789.34亿元", "change": "-6.3%" }, { "label": "经营现金流", "value": "1,149亿元", "change": "+37.0%" }, { "label": "现金转化 / FCF", "value": "1.46× / 539亿元", "change": "FCF +111.6%" } ], "reason": "2026H1报表口径营收、利润分别下降1.1%和6.3%，但剔除增值税适用范围政策调整后均实现可比增长；经营现金流 +37.0%，自由现金流539亿元、同比 +111.6%。通信服务收入仍下降5.7%，分红覆盖、算力资本回报和实时估值仍待核。", "catalysts": ["算力收入转化为自由现金流", "资本开支下降", "通信服务收入企稳"], "valuation_gate": "通信服务收入不连续两个报告期负增长；自由现金流/现金分红≥1.2，算力资本开支回报可解释，且实时估值留有安全边际。", "gate_bands": { "pass": "自由现金流覆盖分红≥1.2、通信服务收入恢复正增长，资本开支回报可解释，实时估值通过。", "watch": "自由现金流已披露但分红覆盖、算力资本回报或实时估值尚未拆清。", "fail": "经营现金流趋势继续恶化、自由现金流不能覆盖分红，或通信服务连续两个报告期负增长。" }, "hard_fails": ["现金流负增长结构化", "自由现金流无法覆盖分红", "算力资本开支回报率持续低迷"], "source_ids": ["cmcc-h1", "cmcc-annual"] }, { "symbol": "600519", "name": "贵州茅台", "decision": "watch", "layer": "WATCH-2 / 最新事实触发重新评审", "financial_cutoff": "2026H1 / 披露2026-08-15", "committee": { "core": 0, "satellite": 0, "watch": 1, "reject": 4 }, "latest_committee": { "watch": 5, "reject": 0 }, "metrics": [ { "label": "2026H1营收", "value": "907.03亿元", "change": "+1.47%" }, { "label": "归母净利", "value": "445.17亿元", "change": "-1.95%" }, { "label": "经营现金流", "value": "706.91亿元", "change": "+438.84%" }, { "label": "现金转化 / 主品", "value": "1.59× / +2.82%", "change": "现金流含财务公司因素" } ], "reason": "2026H1主品收入和现金转化跨过原重新评审门，但归母仍负增、系列酒下降、合同负债较年末明显减少；现金流大增含财务公司存款变动，不能当作纯酒业回款。", "catalysts": ["批价和渠道库存企稳", "主品收入恢复正增长", "剔除财务公司存款变动后的酒业经营现金流与现金转化改善"], "valuation_gate": "不因历史低估值或品牌标签自动重估；茅台酒收入非负、系列酒降幅收窄、经营现金流/归母净利回到≥0.8后重新评审。", "gate_bands": { "pass": "茅台酒收入恢复正增长、现金转化率≥0.8、渠道库存与批价企稳，且实时估值留有安全边际。", "watch": "主品收入0—5%、现金转化率0.6—0.8，或渠道库存/批价缺少可复核数据。", "fail": "主品收入转负、现金转化率<0.6，或批价与渠道库存继续恶化。" }, "hard_fails": ["主品收入转负", "批价和渠道库存继续恶化", "经营现金流长期低于净利润"], "source_ids": ["moutai-h1", "moutai-annual"] } ], "experts": [ { "id": "duan-yongping-perspective", "name": "段永平式商业模式视角（AI模拟）", "role": "商业模式、用户价值、现金流与估值纪律", "round1": { "cycle": "把市场定义为估值不贵、方向未明、情绪退潮的结构性磨底；反对用指数点位替代企业价值。", "scenarios": "基准50 / 乐观20 / 悲观30", "preferred": ["高股息与银行", "AI真实需求", "品牌消费困境反转", "新能源储能", "出海制造"], "stocks": ["贵州茅台", "宁德时代", "中国移动", "招商银行", "工商银行"], "objections": ["黄金不产现金流，不能自动叫稳健", "预测指数整数点位不可复用"], "questions": ["周期四阶段如何事前证伪？", "题材如何转成最终用户现金流？", "AI资本开支何时从投资变成军备竞赛？"] }, "round2": { "rebuttals": ["资金弱转强是结果而非生意变好的第一因", "安全边际若不定义相对什么就只是口号"], "accepted_revision": "承认现金流也是后视镜，必须拆分主营回款、一次性授权、处置与资本开支，并看连续趋势。", "theme_ratings": { "dividend": "WATCH", "grid_ai": "WATCH", "manufacturing": "WATCH", "pharma": "WATCH", "consumption": "WATCH" }, "stock_ratings": { "600941": "WATCH", "600900": "CORE", "000333": "WATCH", "600519": "REJECT", "300750": "SATELLITE", "600276": "SATELLITE" }, "scenarios": "基准45 / 乐观25 / 悲观30", "gates": ["现金流必须来自主营且连续两期同向", "成长主题必须有最终付费用户", "估值未知不得给CORE执行结论"] } }, { "id": "hunjianglong-perspective", "name": "混江龙式题材周期视角（AI模拟）", "role": "题材、情绪周期、资金确认与退出纪律", "round1": { "cycle": "缩量混沌、弱势极限偏后段；政策底已亮牌但资金底未确认，主线从讲故事切向业绩兑现。", "scenarios": "基准55 / 乐观25 / 悲观20", "preferred": ["国产算力与半导体", "具身智能", "红利水电", "金铜资源", "储能"], "stocks": ["中芯国际", "寒武纪", "宁德时代", "紫金矿业", "长江电力", "汇川技术"], "objections": ["成交缩量不能机械等同于全面离场", "科技是从叙事转业绩，不是全部退潮"], "questions": ["政策底怎样传到资金底？", "高增长能否支撑估值？", "如何事前区分缩量筑底与无量阴跌？"] }, "round2": { "rebuttals": ["静态现金流不能替代周期确认，且价格合算必须有估值锚", "供需框架若不给产能、库存和价格拐点就不可证伪"], "accepted_revision": "接受资金弱转强可能反复假启动，升级为资金确认与盈利/现金流确认双门槛。", "theme_ratings": { "dividend": "WATCH", "grid_ai": "WATCH", "manufacturing": "WATCH", "pharma": "PASS", "consumption": "REJECT" }, "stock_ratings": { "600941": "WATCH", "600900": "CORE", "000333": "SATELLITE", "600519": "REJECT", "300750": "CORE", "600276": "CORE" }, "scenarios": "基准55 / 乐观25 / 悲观20", "gates": ["下一财报现金流转负即降级", "成长必须有板块广度与成交确认", "估值透支不得给CORE"] } }, { "id": "munger-perspective", "name": "芒格式反证视角（AI模拟）", "role": "逆向、激励、偏误、拥挤与最强反证", "round1": { "cycle": "缩量退潮的磨底区，不在顶部也不在亢奋；政策底不等于主升。", "scenarios": "基准60 / 乐观20 / 悲观20", "preferred": ["红利现金流", "金铜资源", "高端芯片和基础软件", "创新药"], "stocks": ["贵州茅台", "长江电力", "中国神华", "中钨高新", "紫金矿业"], "objections": ["政策底已现不等于全面牛市", "高股息不是闭眼躺赢"], "questions": ["给出带日期的可证伪触发器", "增收不增利是周期还是结构？", "估值锚究竟是什么？"] }, "round2": { "rebuttals": ["高股息标签若不追现金来源就架空自己的标准", "等资金弱转强是把择时打扮成行业研究"], "accepted_revision": "承认能力圈偏见会错杀宁德、恒瑞；改用可验证现金流和竞争位置，而非按行业类别直接否决。", "theme_ratings": { "dividend": "WATCH", "grid_ai": "WATCH", "manufacturing": "WATCH", "pharma": "WATCH", "consumption": "REJECT" }, "stock_ratings": { "600941": "REJECT", "600900": "CORE", "000333": "SATELLITE", "600519": "REJECT", "300750": "SATELLITE", "600276": "WATCH" }, "scenarios": "基准50 / 乐观30 / 悲观20", "gates": ["现金流连续覆盖派息与再投资", "盈利底用利润和现金流确认", "估值未知时不为优质付溢价"] } }, { "id": "warren-buffett-perspective", "name": "巴菲特式所有者收益视角（AI模拟）", "role": "护城河、所有者收益、资本配置与安全边际", "round1": { "cycle": "不预测短期点位，把周期翻译成价格相对内在价值、利率重力和谁被迫卖；政策底到盈利底有时滞。", "scenarios": "基准55 / 乐观20 / 悲观25", "preferred": ["现金流与高股息", "电力与电网", "消费龙头困境反转", "出海制造", "大盘蓝筹"], "stocks": ["贵州茅台", "长江电力", "招商银行", "中国神华", "美的集团", "宁德时代"], "objections": ["政策底不等于马上牛市", "周期利润不能冒充永续高股息"], "questions": ["周期拐点如何落到估值锚？", "政策底到盈利底有何实证？", "利率在模型中权重多大？"] }, "round2": { "rebuttals": ["成交和资金回答别人是否出价，不回答企业能产多少现金", "注意力不是价值，短缺资本开支会制造过剩"], "accepted_revision": "承认高派息不等于所有者收益、品牌护城河未必转成当期现金；高股息降为逐股验证。", "theme_ratings": { "dividend": "WATCH", "grid_ai": "WATCH", "manufacturing": "REJECT", "pharma": "WATCH", "consumption": "WATCH" }, "stock_ratings": { "600941": "WATCH", "600900": "CORE", "000333": "SATELLITE", "600519": "WATCH", "300750": "SATELLITE", "600276": "SATELLITE" }, "scenarios": "磨底50 / 结构弱复苏35 / 全面转强15", "gates": ["派息与经营现金流背离即剔除", "十年赚钱形态想不清进too hard", "价格不给犯错余地就等待"] } }, { "id": "sun-yuchen-perspective", "name": "孙宇晨式供需与注意力视角（AI模拟）", "role": "供需、库存、资本开支、注意力与叙事拥挤", "round1": { "cycle": "大幅回调后的修复与再平衡；不是普涨起点，注意力会从故事转向盈利兑现。", "scenarios": "基准50 / 乐观25 / 悲观25", "preferred": ["存储周期", "国产算力", "人形机器人", "创新药出海"], "stocks": ["中芯国际", "兆易创新", "华虹公司"], "objections": ["存储涨价不能线性外推", "未来产业合同额和出货量不等于现金利润"], "questions": ["谁在做利润而非流水？", "安全溢价能否抵消盈利下修？", "政策托底如何区分于改变盈利？"] }, "round2": { "rebuttals": ["高派息不等于健康现金流", "资金弱转强若无事前触发器只是事后择时"], "accepted_revision": "承认创新药是IP周期而非产能周期；把短缺拆成产能周期与IP周期，并新增估值门禁。", "theme_ratings": { "dividend": "WATCH", "grid_ai": "PASS", "manufacturing": "WATCH", "pharma": "PASS", "consumption": "REJECT" }, "stock_ratings": { "600941": "REJECT", "600900": "CORE", "000333": "WATCH", "600519": "REJECT", "300750": "CORE", "600276": "SATELLITE" }, "scenarios": "基准45 / 乐观30 / 悲观25", "gates": ["核心标的下一季度现金流转负即降级", "利用率和价格两季下行触发过剩门", "社零或核心CPI转负整体降风险"] } } ], "view_gates": { "criteria": [ { "id": "fact", "name": "事实门", "rule": "关键事实必须来自一手来源，带发布日期与数据时点；专家二手引用不得直接进入事实层。" }, { "id": "mechanism", "name": "机制门", "rule": "必须写清政策/供需如何传导到订单、利润与现金流，禁止只报题材名称。" }, { "id": "quality", "name": "质量门", "rule": "个股须拆解经营现金流、利润、资本开支与一次性收入；高派息和高增长都不能替代。" }, { "id": "valuation", "name": "估值门", "rule": "当前估值、机会成本和安全边际未知时，只能列研究池，不能给立即买入结论。" }, { "id": "falsifier", "name": "反证门", "rule": "每条主题和个股观点必须有可观测硬失效条件及降级动作。" }, { "id": "council", "name": "会商门", "rule": "至少一位长期价值视角与一位周期视角认可，且不存在未解决的事实或偿债硬否决。" } ], "results": [ { "name": "长江电力", "fact": "pass", "mechanism": "pass", "quality": "watch", "valuation": "open", "falsifier": "pass", "council": "pass", "action": "WATCH；补自由现金流与实时利差" }, { "name": "美的集团", "fact": "pass", "mechanism": "pass", "quality": "watch", "valuation": "open", "falsifier": "pass", "council": "pass", "action": "WATCH；复核现金转化" }, { "name": "宁德时代", "fact": "pass", "mechanism": "pass", "quality": "watch", "valuation": "open", "falsifier": "pass", "council": "pass", "action": "WATCH；补产能回报与实时估值" }, { "name": "恒瑞医药", "fact": "pass", "mechanism": "pass", "quality": "watch", "valuation": "open", "falsifier": "pass", "council": "pass", "action": "WATCH；单期现金失守，等待第二期证伪" }, { "name": "中国移动", "fact": "pass", "mechanism": "watch", "quality": "watch", "valuation": "open", "falsifier": "pass", "council": "pass", "action": "WATCH；补分红覆盖、资本回报与实时估值" }, { "name": "贵州茅台", "fact": "pass", "mechanism": "watch", "quality": "watch", "valuation": "open", "falsifier": "pass", "council": "pass", "action": "WATCH；触发重新评审但不升级" } ] }, "monitor_switches": [ "工业增加值累计同比是否连续三期达到6%或跌到4%", "社零累计同比是否连续三期达到3%或跌到0%", "地产销售额降幅是否连续三期收窄至-5%以内或扩大至-15%", "PPI环比是否连续三个月同向", "工业利润是否不再依赖电子行业贡献近半增量", "政府性基金收入是否连续两期改善至-5%以上", "信用结构分项与M1-M2剪刀差（待接入官方冻结序列）", "A股成交与市场宽度（待接入可复现冻结基线）", "主题企业订单、毛利率和自由现金流能否同时改善", "六股实时估值与机会成本是否首次通过门禁" ], "limitations": [ "五个AI方法论角色使用同一headless profile与同一运行环境，具体模型配置未冻结；观点相关，3/5或5/5不是统计胜率。", "情景状态机阈值没有历史校准；它只保证规则互斥可复算，必须在未来逐月冻结回看。", "本报告没有给出实时价格、目标价或当前PE；估值门保持未完成，故股票只属于观察池。", "公司财报时点不完全一致；每个财报季必须重跑门禁，旧快照投票不得覆盖新事实。", "两轮会商仅保存结构化摘要，原始逐字转录与run/session ID未纳入仓库，因此不是无损审计日志。", "A股成交、宽度与相对趋势尚无冻结行情基线；当前周期结论是宏观/盈利假设，不是技术面定论。", "六股观察池由当前已上市的大市值标的主观筛选，不能代表全A股，会产生选择偏差与制度依赖。", "主题和股票可能高度相关，不能把多个专家或多个主题的支持次数相加成组合胜率。" ], "sources": [ { "id": "nbs-gdp", "publisher": "国家统计局", "date": "2026-07-16", "title": "2026年上半年国民经济运行情况", "url": "https://www.stats.gov.cn/sj/zxfb/202607/t20260716_1964142.html" }, { "id": "nbs-july", "publisher": "国家统计局", "date": "2026-08-17", "title": "2026年7月份国民经济运行情况", "url": "https://www.stats.gov.cn/sj/zxfb/202608/t20260817_1965056.html" }, { "id": "nbs-retail", "publisher": "国家统计局", "date": "2026-08-17", "title": "2026年1—7月份社会消费品零售总额", "url": "https://www.stats.gov.cn/sj/zxfbhjd/202608/t20260817_1965052.html" }, { "id": "nbs-services", "publisher": "国家统计局", "date": "2026-08-17", "title": "国家统计局新闻发言人就2026年7月份国民经济运行情况答记者问", "url": "https://www.stats.gov.cn/zwfwck/sjfb/202608/t20260817_1965064.html" }, { "id": "nbs-pmi", "publisher": "国家统计局", "date": "2026-07-31", "title": "2026年7月中国采购经理指数运行情况", "url": "https://www.stats.gov.cn/sj/zxfbhjd/202607/t20260731_1964253.html" }, { "id": "nbs-prices", "publisher": "国家统计局", "date": "2026-08-09", "title": "2026年7月份CPI和PPI数据解读", "url": "https://www.stats.gov.cn/sj/zxfbhjd/202608/t20260809_1965009.html" }, { "id": "nbs-profits", "publisher": "国家统计局", "date": "2026-07-27", "title": "2026年上半年工业企业利润解读", "url": "https://www.stats.gov.cn/sj/zxfbhjd/202607/t20260727_1964193.html" }, { "id": "mof-h1", "publisher": "财政部", "date": "2026-07-22", "title": "2026年上半年财政收支情况", "url": "https://gks.mof.gov.cn/tongjishuju/202607/t20260722_3993943.htm" }, { "id": "lpr", "publisher": "中国货币网 / 中国人民银行授权", "date": "2026-08-20", "title": "2026年8月20日LPR公告", "url": "https://www.chinamoney.com.cn/chinese/rdgz/20260820/3399885.html" }, { "id": "gov-work-report", "publisher": "中国政府工作报告（辽宁省政府转载）", "date": "2026-03-16", "title": "2026年政府工作报告", "url": "https://www.ln.gov.cn/web/zwgkx/zfgzbg/zyzfgzbg/2026031609022955591/index.shtml" }, { "id": "nea-grid", "publisher": "国务院国资委 / 国家电网", "date": "2026-01-19", "title": "国家电网“十五五”计划投资4万亿元建设新型电力系统", "url": "https://www.sasac.gov.cn/n2588025/n2588124/c35325777/content.html" }, { "id": "ndrc-tradein", "publisher": "国家发展改革委", "date": "2026-06-26", "title": "消费品以旧换新阶段性数据", "url": "https://www.ndrc.gov.cn/xwdt/ztzl/tddgmsbgxhxfpyjhx/gzdt/202606/t20260626_1406119_ext.html" }, { "id": "cmcc-annual", "publisher": "巨潮资讯 / 中国移动", "date": "2026-03-27", "title": "中国移动2025年年度报告摘要", "url": "https://static.cninfo.com.cn/finalpage/2026-03-27/1225036258.PDF" }, { "id": "cmcc-h1", "publisher": "港交所 / 中国移动", "date": "2026-08-13", "title": "中国移动2026年中期业绩公告", "url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0813/2026081300218.pdf" }, { "id": "cypc-annual", "publisher": "巨潮资讯 / 长江电力", "date": "2026-04-30", "title": "长江电力2025年年度报告", "url": "https://static.cninfo.com.cn/finalpage/2026-04-30/1225262036.PDF" }, { "id": "cypc-q1", "publisher": "巨潮资讯 / 长江电力", "date": "2026-04-30", "title": "长江电力2026年第一季度报告", "url": "https://static.cninfo.com.cn/finalpage/2026-04-30/1225262110.PDF" }, { "id": "midea-annual", "publisher": "巨潮资讯 / 美的集团", "date": "2026-03-31", "title": "美的集团2025年年度报告摘要", "url": "https://static.cninfo.com.cn/finalpage/2026-03-31/1225058109.PDF" }, { "id": "midea-q1", "publisher": "巨潮资讯 / 美的集团", "date": "2026-04-30", "title": "美的集团2026年第一季度报告", "url": "https://static.cninfo.com.cn/finalpage/2026-04-30/1225259066.PDF" }, { "id": "catl-annual", "publisher": "巨潮资讯 / 宁德时代", "date": "2026-03-10", "title": "宁德时代2025年年度报告", "url": "https://static.cninfo.com.cn/finalpage/2026-03-10/1225002214.PDF" }, { "id": "catl-h1", "publisher": "港交所 / 宁德时代", "date": "2026-07-26", "title": "宁德时代2026年中期报告", "url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0726/2026072600031.pdf" }, { "id": "hengrui-annual", "publisher": "港交所 / 恒瑞医药", "date": "2026-03-25", "title": "恒瑞医药2025年年度报告", "url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032502087_c.pdf" }, { "id": "hengrui-h1", "publisher": "港交所 / 恒瑞医药（A股海外监管公告）", "date": "2026-08-19", "title": "恒瑞医药2026年半年度报告", "url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0819/2026081901589_c.pdf" }, { "id": "moutai-annual", "publisher": "巨潮资讯 / 贵州茅台", "date": "2026-04-17", "title": "贵州茅台2025年年度报告", "url": "https://static.cninfo.com.cn/finalpage/2026-04-17/1225114741.PDF" }, { "id": "moutai-h1", "publisher": "贵州茅台", "date": "2026-08-15", "title": "贵州茅台2026年半年度报告", "url": "https://www.moutaichina.com/mtgf/articleFileDir/2026-08/17/277c9b776bff4ae89dde75e987437760.pdf" }, { "id": "nari-annual", "publisher": "巨潮资讯 / 国电南瑞", "date": "2026-04-30", "title": "国电南瑞2025年年度报告", "url": "https://static.cninfo.com.cn/finalpage/2026-04-30/1225257886.PDF" }, { "id": "smic-q2", "publisher": "港交所 / 中芯国际", "date": "2026-08-13", "title": "中芯国际2026年第二季度报告", "url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0813/2026081300353.pdf" } ] }